Patent Assignment
Reel/Frame 048521/0005
Release of Security Interest
Recorded: 2019-03-06
Pages: 15
Assignor
CRG SERVICING LLC
Executed: 2019-03-06
Assignee
SYNERGY PHARMACEUTICALS INC.
TWO EXECUTIVE DRIVE, SUITE 450, SOMERSET, NEW JERSEY, 08873
Covered Properties
(50)
Compositions and Method for the Treatment and Detection of Colon Cancer
PCT:
PCT/US2016/062902 ↗
Formulations and Methods for Treating Ulcerative Colitis
PCT:
PCT/US2017/013017 ↗
Guanylate Cyclase Receptor Agonists for the Treatment of Tissue Inflammation and Carcinogenesis
Guanylate Cyclase Receptor Agonists for the Treatment of Tissue Inflammation and Carcinogenesis
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Guanylate Cyclase Receptor Agonists for the Treatment of Tissue Inflammation and Carcinogenesis
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Method of Inhibiting Bile Acid Absorption by Administering An Agonist of a Guanylate Cyclase Receptor
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Process of Preparing Guanylate Cyclase C Agonists
Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
Application:
14/137,256 →
Publication:
US 2014/0121169
Agonists of Guanylate Cyclase and Their Uses
Compositions Useful For The Treatment Of Gastrointestinal Disorders
Agonists Of Guanylate Cyclase And Their Uses
Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Agonists of Guanylate Cyclase Useful for the Treatment of Opioid Induced Dysfunctions
Application:
14/944,499 →
Publication:
US 2016/0367622
Agonists of Guanylate Cyclase Useful for Downregulation of Pro-Inflammatory Cytokines
Application:
15/026,560 →
Publication:
US 2016/0235807
Agonists of Guanylate Cyclase Useful for the Treatment of Opioid Induced Dysfunctions
Application:
15/026,563 →
Publication:
US 2016/0220630
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Application:
15/184,574 →
Publication:
US 2016/0367623
Compositions Useful for the Treatment of Gastrointestinal Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Application:
15/297,688 →
Publication:
US 2017/0029468
Agonists of Guanylate Cyclase and Their Uses
Process of Preparing Guanylate Cyclase C Agonisys
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase and Their Uses
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Application:
15/918,047 →
Publication:
US 2018/0273586
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Application:
16/018,278 →
Publication:
US 2020/0009063
Agonists of Guanylate Cyclase and Their Uses
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 8, 2008
From: SHAILUBHAI, KUNWAR; JACOB, GARY S.
To: SYNERGY PHARMACEUTICALS, INC.
Reel/Frame 021645/0957 →
Assignment of Assignor's Interest
Apr 1, 2013
From: SHAILUBHAI, KUNWAR; JACOB, GARY S.
To: SYNERGY PHARMACEUTICALS, INC.
Reel/Frame 030125/0152 →
Assignment of Assignor's Interest
May 28, 2013
From: SHAILUBHAI, KUNWAR; JACOB, GARY S.
To: SYNERGY PHARMACEUTICALS, INC.
Reel/Frame 030495/0216 →
Assignment of Assignor's Interest
Feb 24, 2020
From: SHAILUBHAI, KUNWAR; JACOB, GARY S.; GRIFFIN, PATRICK H.
To: SYNERGY PHARMACEUTICALS, INC.
Reel/Frame 051904/0302 →
Assignment of Assignor's Interest
Apr 1, 2020
From: SYNERGY PHARMACEUTICALS, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 052285/0550 →
Assignment of Assignor's Interest
Apr 9, 2020
From: SYNERGY PHARMACEUTICALS INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 052358/0134 →
Assignment of Assignor's Interest
Jun 26, 2020
From: SYNERGY PHARMACEUTICALS INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 053055/0239 →
Assignment of Assignor's Interest
Jul 30, 2020
From: SYNERGY PHARMACEUTICALS, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 053359/0680 →
Assignment of Assignor's Interest
Sep 28, 2020
From: SYNERGY PHARMACEUTICALS, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 053903/0061 →
Assignment of Assignor's Interest
Jan 4, 2021
From: SYNERGY PHARMACEUTICALS, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 054795/0458 →
Assignment of Assignor's Interest
Mar 29, 2021
From: SYNERGY PHARMACEUTICALS, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 055748/0846 →
Assignment of Assignor's Interest
Jun 29, 2021
From: SYNERGY PHARMACEUTICALS INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 056706/0105 →
Security Interest
Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Assignment of Assignor's Interest
Oct 26, 2021
From: SYNERGY PHARMACEUTICALS INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 057914/0679 →
Assignment of Assignor's Interest
May 9, 2022
From: SYNERGY PHARMACEUTICALS, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 059874/0544 →
Security Interest
Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Assignment of Assignor's Interest
Jul 8, 2022
From: SYNERGY PHARMACEUTICALS, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 060466/0386 →
Assignment of Assignor's Interest
Jul 8, 2022
From: SYNERGY PHARMACEUTICALS, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 060464/0415 →
Assignment of Assignor's Interest
Jul 8, 2022
From: SYNERGY PHARMACEUTICALS INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 060463/0503 →
Security Agreement (First Lien)
Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Agreement (First Lien)
Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
Security Agreement (Second Lien)
Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
U.S. Patent Security Agreement
Nov 25, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0375 →